These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45 related articles for article (PubMed ID: 2483059)
1. [HIV infection: results of 4 years of observation (May 1984-May 1988)- of the admitting department of the V. Cervello Hospital in Palermo]. Ajello O; Cangelosi C; D'Accardo AM; D'Agostino S; Firaux R; Giardina AR; Majolino I; Marcianò R; Menozzi M; Patti S Ann Ig; 1989; 1(1-2):125-32. PubMed ID: 2483059 [TBL] [Abstract][Full Text] [Related]
2. Prevalence, patterns, and course of past hepatitis B virus infection in intravenous drug users with HIV-1 infection. Rodríguez-Méndez ML; González-Quintela A; Aguilera A; Barrio E Am J Gastroenterol; 2000 May; 95(5):1316-22. PubMed ID: 10811346 [TBL] [Abstract][Full Text] [Related]
3. Association of HCV and HBV markers in Spanish HIV-seropositive patients in relation to risk practices. Rodríguez-Méndez ML; González-Quintela A; Aguilera A; Carballo E; Barrio E Hepatogastroenterology; 2003; 50(54):2093-7. PubMed ID: 14696471 [TBL] [Abstract][Full Text] [Related]
4. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission. Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605 [TBL] [Abstract][Full Text] [Related]
5. Relevance of intravenous cocaine use in relation to prevalence of HIV, hepatitis B and C virus markers among intravenous drug abusers in southern Italy. Guadagnino V; Zimatore G; Izzi A; Caroleo B; Rocca A; Montesano F; Costa C; Masciari R; Naso E; Biselli R J Clin Lab Immunol; 1995; 47(1):1-9. PubMed ID: 8735431 [TBL] [Abstract][Full Text] [Related]
6. Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy. Sheng WH; Kao JH; Chen PJ; Huang LM; Chang SY; Sun HY; Hung CC; Chen MY; Chang SC Clin Infect Dis; 2007 Nov; 45(9):1221-9. PubMed ID: 17918088 [TBL] [Abstract][Full Text] [Related]
7. Seroepidemiology of hepatitis B, delta and human immunodeficiency virus infections in Hamadan province, Iran: a population based study. Amini S; Mahmoodi MF; Andalibi S; Solati AA J Trop Med Hyg; 1993 Oct; 96(5):277-87. PubMed ID: 8411302 [TBL] [Abstract][Full Text] [Related]
8. Correlates of HIV, HBV, and HCV infections in a prison inmate population: results from a multicentre study in Italy. Babudieri S; Longo B; Sarmati L; Starnini G; Dori L; Suligoi B; Carbonara S; Monarca R; Quercia G; Florenzano G; Novati S; Sardu A; Iovinella V; Casti A; Romano A; Uccella I; Maida I; Brunetti B; Mura MS; Andreoni M; Rezza G J Med Virol; 2005 Jul; 76(3):311-7. PubMed ID: 15902712 [TBL] [Abstract][Full Text] [Related]
9. Serological markers for hepatitis B and treponemal infection among HIV carriers from Ethiopia. Alkan ML; Maayan S; Belmaker I; Arbeli Y; Mani N; Ben-Yshai F Isr J Med Sci; 1993; 29(6-7):390-2. PubMed ID: 8349459 [TBL] [Abstract][Full Text] [Related]
10. Impact of occult hepatitis B virus infection in HIV patients naive for antiretroviral therapy. Filippini P; Coppola N; Pisapia R; Scolastico C; Marrocco C; Zaccariello A; Nacca C; Sagnelli C; De Stefano G; Ferraro T; De Stefano C; Sagnelli E AIDS; 2006 Jun; 20(9):1253-60. PubMed ID: 16816553 [TBL] [Abstract][Full Text] [Related]
11. Evidence of multiple hepatitis virus infections in autopsied materials of intravenous drug addicts. Schleicher S; Schieffer M; Jürgens S; Wehner HD; Flehmig B Ig Sanita Pubbl; 2005; 61(5):435-50. PubMed ID: 17214028 [TBL] [Abstract][Full Text] [Related]
12. Seroprevalence of chronic hepatitis B virus infection among taiwanese human immunodeficiency virus type 1-positive persons in the era of nationwide hepatitis B vaccination. Sun HY; Ko WC; Tsai JJ; Lee HC; Liu CE; Wong WW; Su SC; Ho MW; Cheng SH; Yang CH; Lin YH; Miao WJ; Sheng WH; Hung CC Am J Gastroenterol; 2009 Apr; 104(4):877-84. PubMed ID: 19259078 [TBL] [Abstract][Full Text] [Related]
13. Prevalence of antibodies against hepatitis C virus and hepatitis B coinfection in healthy population in Bulgaria. A seroepidemiological study. Atanasova MV; Haydouchka IA; Zlatev SP; Stoilova YD; Iliev YT; Mateva NG Minerva Gastroenterol Dietol; 2004 Mar; 50(1):89-96. PubMed ID: 15719010 [TBL] [Abstract][Full Text] [Related]
14. Hepatitis B, C seroprevalence and delta viruses in HIV-1 Senegalese patients at HAART initiation (retrospective study). Diop-Ndiaye H; Touré-Kane C; Etard JF; Lô G; Diaw P; Ngom-Gueye NF; Gueye PM; Ba-Fall K; Ndiaye I; Sow PS; Delaporte E; Mboup S J Med Virol; 2008 Aug; 80(8):1332-6. PubMed ID: 18551596 [TBL] [Abstract][Full Text] [Related]
15. Hepatitis B virus infection among people attending the voluntary counselling and testing centre and anti-retroviral therapy clinic of St Paul's General Specialised Hospital, Addis Ababa, Ethiopia. Shimelis T; Torben W; Medhin G; Tebeje M; Andualm A; Demessie F; Mulu A; Tegbaru B; Gebre-Selassie S Sex Transm Infect; 2008 Feb; 84(1):37-41. PubMed ID: 17804606 [TBL] [Abstract][Full Text] [Related]
16. [Infection by HIV and the hepatitis B, C, and D viruses in intravenous drug addicts. Seroprevalence at 1 year and its follow-up]. Delgado-Iribarren A; Wilhelmi I; Padilla B; Cañedo T; Gómez J; Elviro J Enferm Infecc Microbiol Clin; 1993 Jan; 11(1):8-13. PubMed ID: 8384891 [TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus co-infection in HIV infected patients. Sud A; Singh J; Dhiman RK; Wanchu A; Singh S; Chawla Y Trop Gastroenterol; 2001; 22(2):90-2. PubMed ID: 11552493 [TBL] [Abstract][Full Text] [Related]